Latest News and Press Releases

The following people have been appointed as members of Vitrolife’s election committee for the Annual General Meeting in 2013: Henrik Blomquist, representing Bure Equity AB Johan Ståhl, representing...

On June 29 Vitrolife announced that the company had entered into an agreement to acquire 100% ownership in Cryo Management Ltd. Vitrolife has now completed the transaction and Cryo Management Ltd is...

Vitrolife informerade den 29 juni om att bolaget har ingått avtal om att förvärva samtliga andelar i Cryo Management Ltd. Vitrolife har nu slutfört affären och Cryo Management Ltd är numera en del av...

Den 1 oktober knoppades Xvivo Perfusion AB av från Vitrolife AB där aktieägarna i Vitrolife erhöll en aktie i Xvivo Perfusion för varje aktie i Vitrolife. Xvivo Perfusions aktie har godkänts för...

Xvivo Perfusion AB was spun off from Vitrolife AB on October 1, whereby Vitrolife shareholders received one share in Xvivo Perfusion for each share in Vitrolife. Xvivo Perfusion shares have been...

Efter att beslut har fattats att knoppa av Vitrolifes transplantationsverksamhet har Vitrolifes styrelse fastställt nya finansiella mål för bolaget. Vitrolifes nya finansiella mål lyder: Vitrolifes...

After the adoption of a resolution to spin off Vitrolife’s transplantation business, Vitrolife’s Board has set new financial objectives for the company. Vitrolife’s new financial objectives are as...

1. Beslutades om efterutdelning till aktieägarna av bolagets aktier i dotterbolaget Xvivo Perfusion AB där en (1) befintlig aktie i Vitrolife AB ger rätt till en (1) aktie i Xvivo Perfusion AB i...

In accordance with the resolution adopted by the Extraordinary General Meeting of shareholders held on September 24, Vitrolife’s transplantation business, which is run in the subsidiary Xvivo...

1. The meeting adopted a resolution to distribute shares in the subsidiary Xvivo Perfusion AB to company shareholders, whereby one (1) existing share in Vitrolife AB entitles shareholders to...